ctrl K

AI Score

Unlock

TriSalus Life Sciences In... (TLSI)

AI Score

Unlock

5.58

-0.04 (-0.71%)

At close: Mar 31, 2025, 12:33 PM

TriSalus Life Sciences Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20
Revenue	18.51M	12.4M	8.4M	5.43M
Cost of Revenue	2.6M	2.26M	1.19M	2.2M
Gross Profit	15.91M	10.14M	7.21M	3.24M
Operating Income	-54.15M	-36.44M	-24.03M	-25.65M
Interest Income	431K	180K	64K	n/a
Pretax Income	-59.03M	-47.18M	-28.84M	-31.83M
Net Income	-59.04M	-47.19M	-28.84M	-31.83M
Selling & General & Admin	40.55M	25.22M	17.02M	13.06M
Research & Development	29.51M	21.36M	14.22M	15.82M
Other Expenses	n/a	-8.73M	746K	n/a
Operating Expenses	70.06M	46.58M	31.24M	29.02M
Interest Expense	16K	1K	1.76M	n/a
Selling & Marketing Expenses	17.03M	12.74M	8.26M	6.19M
Cost & Expenses	72.66M	48.84M	32.43M	31.22M
Income Tax	9K	9K	3K	4K
Shares Outstanding (Basic)	9.4M	29.61M	31.25M	30.56M
Shares Outstanding (Diluted)	9.4M	29.61M	31.25M	30.56M
EPS (Basic)	-6.73	-1.59	-0.92	-1.04
EPS (Diluted)	-6.73	-1.59	-0.92	-1.04
EBITDA	-58.3M	-46.76M	-23.57M	-25.32M
Depreciation & Amortization	702K	414K	464K	321K